Ajaz Bulbul

550 total citations
20 papers, 348 citations indexed

About

Ajaz Bulbul is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Ajaz Bulbul has authored 20 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 4 papers in Surgery. Recurrent topics in Ajaz Bulbul's work include Lung Cancer Treatments and Mutations (5 papers), Vascular Tumors and Angiosarcomas (3 papers) and Sarcoma Diagnosis and Treatment (3 papers). Ajaz Bulbul is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), Vascular Tumors and Angiosarcomas (3 papers) and Sarcoma Diagnosis and Treatment (3 papers). Ajaz Bulbul collaborates with scholars based in United States, Dominica and China. Ajaz Bulbul's co-authors include Hatim Husain, John Paul Shen, Fernando J. López-Díaz, Brian Woodward, Scott M. Lippman, Joanne Xiu, Andrea Hayes‐Jordan, Bridget N. Fahy, Ru Jia and Xuefeng Xia and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Ajaz Bulbul

18 papers receiving 344 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ajaz Bulbul United States 7 206 171 112 75 48 20 348
Michele Fernandes United States 5 209 1.0× 143 0.8× 144 1.3× 49 0.7× 49 1.0× 5 383
Pablo Berlanga France 12 167 0.8× 181 1.1× 186 1.7× 97 1.3× 49 1.0× 54 492
Mar Abad Spain 11 121 0.6× 172 1.0× 221 2.0× 57 0.8× 40 0.8× 25 483
Ivan Donev Bulgaria 12 164 0.8× 207 1.2× 250 2.2× 132 1.8× 41 0.9× 36 491
Teresa M. Hopper United States 4 231 1.1× 204 1.2× 243 2.2× 101 1.3× 46 1.0× 6 486
Keita Masuzawa Japan 10 285 1.4× 239 1.4× 190 1.7× 67 0.9× 35 0.7× 24 418
Ngoc T. Hoang United States 6 200 1.0× 155 0.9× 274 2.4× 130 1.7× 29 0.6× 8 467
Domenico Germano Italy 10 122 0.6× 178 1.0× 137 1.2× 34 0.5× 34 0.7× 22 410
T. Christopher Windham United States 7 110 0.5× 177 1.0× 203 1.8× 35 0.5× 61 1.3× 14 438

Countries citing papers authored by Ajaz Bulbul

Since Specialization
Citations

This map shows the geographic impact of Ajaz Bulbul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ajaz Bulbul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ajaz Bulbul more than expected).

Fields of papers citing papers by Ajaz Bulbul

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ajaz Bulbul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ajaz Bulbul. The network helps show where Ajaz Bulbul may publish in the future.

Co-authorship network of co-authors of Ajaz Bulbul

This figure shows the co-authorship network connecting the top 25 collaborators of Ajaz Bulbul. A scholar is included among the top collaborators of Ajaz Bulbul based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ajaz Bulbul. Ajaz Bulbul is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bulbul, Ajaz, Alessandro Leal, & Hatim Husain. (2020). Applications of cell-free circulating tumor DNA detection in EGFR mutant lung cancer. Journal of Thoracic Disease. 12(5). 2877–2882. 10 indexed citations
2.
Bulbul, Ajaz, John Paul Shen, Brian Woodward, et al.. (2019). Novel Third-Generation EGFR Tyrosine Kinase Inhibitors and Strategies to Overcome Therapeutic Resistance in Lung Cancer. Cancer Research. 79(4). 689–698. 164 indexed citations
3.
Wang, Yan, Chuanhua Zhao, Lianpeng Chang, et al.. (2019). Circulating tumor DNA analyses predict progressive disease and indicate trastuzumab-resistant mechanism in advanced gastric cancer. EBioMedicine. 43. 261–269. 62 indexed citations
4.
Bulbul, Ajaz. (2019). Vitiligoid hypopigmentation associated with pembrolizumab in metastatic head and neck cancer. Oxford Medical Case Reports. 2019(3). omz016–omz016. 5 indexed citations
5.
Bulbul, Ajaz & Hatim Husain. (2018). First-Line Treatment in EGFR Mutant Non-Small Cell Lung Cancer: Is There a Best Option?. Frontiers in Oncology. 8. 94–94. 20 indexed citations
6.
Bulbul, Ajaz, et al.. (2018). The Conundrum of Adjuvant HER2 Treatment Options. Frontiers in Oncology. 8. 177–177. 2 indexed citations
7.
Bulbul, Ajaz, et al.. (2018). Reasoning the Effect of Immunotherapy After Chemoradiation in the PACIFIC Trial. Future Oncology. 15(1). 81–94. 3 indexed citations
8.
Bulbul, Ajaz, Patrick M. Forde, Brian Woodward, et al.. (2018). Systemic Treatment Options for Brain Metastases from Non-Small-Cell Lung Cancer.. PubMed. 32(4). 156–63. 11 indexed citations
9.
Bulbul, Ajaz, John Paul Shen, Joanne Xiu, Pablo Tamayo, & Hatim Husain. (2018). Genomic and Proteomic Alterations in Desmoplastic Small Round Blue-Cell Tumors. JCO Precision Oncology. 2(2). 1–9. 11 indexed citations
10.
Bulbul, Ajaz. (2018). Immunogenic cell death: Chemoimmunotherapy in the clinic. 2(2). 2 indexed citations
11.
Bulbul, Ajaz. (2018). Lacrimal gland adenocarcinoma responding to checkpoint inhibition and androgen deprivation. Oxford Medical Case Reports. 2018(9). omy066–omy066. 3 indexed citations
12.
Bulbul, Ajaz, et al.. (2018). Opioid dose reduction and pain control with medical cannabis.. Journal of Clinical Oncology. 36(34_suppl). 189–189. 2 indexed citations
13.
Bulbul, Ajaz, et al.. (2018). Alternate Day Oral Iron Dosing in Iron Deficiency Anemia. Blood. 132(Supplement 1). 4891–4891. 1 indexed citations
14.
15.
Bulbul, Ajaz, et al.. (2017). Desmoplastic Small Round Blue Cell Tumor: A Review of Treatment and Potential Therapeutic Genomic Alterations. Sarcoma. 2017. 1–12. 40 indexed citations
16.
Bulbul, Ajaz, et al.. (2017). Treatment, logistical, and cost burden of prior authorization in community practice.. Journal of Clinical Oncology. 35(31_suppl). 164–164. 1 indexed citations
17.
Xiu, Joanne, et al.. (2017). Potential therapeutic genomic alterations in desmoplastic small round blue cell tumor.. Journal of Clinical Oncology. 35(15_suppl). 11066–11066. 3 indexed citations
18.
19.
Dorff, Tanya B., Anne Schuckman, Rachel Schwartz, et al.. (2016). Epidermal Growth Factor Receptor, Excision-Repair Cross-Complementation Group 1 Protein, and Thymidylate Synthase Expression in Penile Cancer. Clinical Genitourinary Cancer. 14(5). 450–456.e1. 6 indexed citations
20.
Dorff, Tanya B., Rachel Schwartz, Yanling Ma, et al.. (2011). EGFR, TS, and ERCC1 expression in penile squamous cancer (PSC).. Journal of Clinical Oncology. 29(7_suppl). 219–219. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michele Fernandes Breakdown of academic impact, for papers by Pablo Berlanga Breakdown of academic impact, for papers by Mar Abad Breakdown of academic impact, for papers by Ivan Donev Breakdown of academic impact, for papers by Teresa M. Hopper Breakdown of academic impact, for papers by Keita Masuzawa Breakdown of academic impact, for papers by Ngoc T. Hoang Breakdown of academic impact, for papers by Domenico Germano Breakdown of academic impact, for papers by T. Christopher Windham
Rankless by CCL
2026